anthem | The Savvy Diabetic

Savvy Updates 8/8/22: D Business/Earnings (Tandem, Insulet, Dexcom), Senseonics/Eversense E3 Covered by Anthem, Go to Sleep Before Midnight

Aug 8, 2022 | Featured

Tandem lines up FDA review of new pint-sized insulin pump amid lower-than-expected sales was reported by Andrea Park for FierceBioTech.com, 4 August 2022. After stumbling a bit in the second quarter of the year, Tandem Diabetes is getting back on its feet,...

Savvy Update, 3/14/22: Dexcom G7 Gets CE Mark in EU! Prior Auth Burdens, Verapamil Treats Early T1D, Anthem To Become Elevance Health

Mar 14, 2022 | Featured, Research News, Technology Updates

TODAY! Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management was published by BusinessWire.com, 14 March 2022. DexCom secured CE Mark (Conformité Européenne) for the Dexcom G7...

Savvy Updates 8/8/22: D Business/Earnings (Tandem, Insulet, Dexcom), Senseonics/Eversense E3 Covered by Anthem, Go to Sleep Before Midnight

Savvy Update, 3/14/22: Dexcom G7 Gets CE Mark in EU! Prior Auth Burdens, Verapamil Treats Early T1D, Anthem To Become Elevance Health

Email Alerts

You have Successfully Subscribed!

Recent Posts

Categories

About Us

Explore The Savvy Diabetic

Follow Us